BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ödén J, Toma‐dasu I, Witt Nyström P, Traneus E, Dasu A. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment‐related toxicities following proton therapy for intracranial tumors. Med Phys 2020;47:342-51. [DOI: 10.1002/mp.13911] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Kalholm F, Grzanka L, Toma-Dasu I, Bassler N. Modeling RBE with other quantities than LET significantly improves prediction of in vitro cell survival for proton therapy. Med Phys 2023;50:651-9. [PMID: 36321465 DOI: 10.1002/mp.16029] [Reference Citation Analysis]
2 Yang Y, Rwigema JM, Vargas C, Yu NY, Keole SR, Wong WW, Schild SE, Bues M, Liu W, Shen J. Technical note: Investigation of dose and LET(d) effect to rectum and bladder by using non-straight laterals in prostate cancer receiving proton therapy. Med Phys 2022;49:7428-37. [PMID: 36208196 DOI: 10.1002/mp.16008] [Reference Citation Analysis]
3 Hahn C, Heuchel L, Ödén J, Traneus E, Wulff J, Plaude S, Timmermann B, Bäumer C, Lühr A. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges. Radiat Oncol 2022;17:169. [PMID: 36273132 DOI: 10.1186/s13014-022-02143-x] [Reference Citation Analysis]
4 Bachiller-perea D, Zhang M, Fleta C, Quirion D, Bassignana D, Gómez F, Guardiola C. Multi-arrays of 3D cylindrical microdetectors for beam characterization and microdosimetry in proton therapy. Front Phys 2022;10:958648. [DOI: 10.3389/fphy.2022.958648] [Reference Citation Analysis]
5 Underwood TSA, McNamara AL, Appelt A, Haviland JS, Sørensen BS, Troost EGC. A systematic review of clinical studies on variable proton Relative Biological Effectiveness (RBE). Radiother Oncol 2022;175:79-92. [PMID: 35988776 DOI: 10.1016/j.radonc.2022.08.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Fredrik Fjæra L, Indelicato DJ, Handeland AH, Ytre-Hauge KS, Lassen-Ramshad Y, Muren LP, Stokkevåg CH. A case-control study of linear energy transfer and relative biological effectiveness related to symptomatic brainstem toxicity following pediatric proton therapy. Radiother Oncol 2022:S0167-8140(22)04220-7. [PMID: 35917900 DOI: 10.1016/j.radonc.2022.07.022] [Reference Citation Analysis]
7 Heuchel L, Hahn C, Pawelke J, Sørensen BS, Dosanjh M, Lühr A. Clinical use and future requirements of relative biological effectiveness: survey among all european proton therapy centres. Radiother Oncol 2022:S0167-8140(22)00266-3. [PMID: 35605747 DOI: 10.1016/j.radonc.2022.05.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Qi Y, Mao L, Lu H, Jin S, Huang J, Wang Z, Zhang J, Wang K. Multi-centric analysis of linear energy transfer distribution from clinical proton beam based on TOPAS. Radiation Physics and Chemistry 2022;194:110035. [DOI: 10.1016/j.radphyschem.2022.110035] [Reference Citation Analysis]
9 Hahn C, Ödén J, Dasu A, Vestergaard A, Fuglsang Jensen M, Sokol O, Pardi C, Bourhaleb F, Leite A, de Marzi L, Smith E, Aitkenhead A, Rose C, Merchant M, Kirkby K, Grzanka L, Pawelke J, Lühr A. Towards harmonizing clinical linear energy transfer (LET) reporting in proton radiotherapy: a European multi-centric study. Acta Oncol 2022;61:206-14. [PMID: 34686122 DOI: 10.1080/0284186X.2021.1992007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Paganetti H. Mechanisms and Review of Clinical Evidence of Variations in Relative Biological Effectiveness in Proton Therapy. Int J Radiat Oncol Biol Phys 2022;112:222-36. [PMID: 34407443 DOI: 10.1016/j.ijrobp.2021.08.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
11 Hwang E, Burnet NG, Crellin AM, Ahern V, Thwaites DI, Gaito S, Chang YC, Smith E. A Novel Model and Infrastructure for Clinical Outcomes Data Collection and Their Systematic Evaluation for UK Patients Receiving Proton Beam Therapy. Clin Oncol (R Coll Radiol) 2021:S0936-6555(21)00344-7. [PMID: 34602320 DOI: 10.1016/j.clon.2021.09.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wagenaar D, Schuit E, van der Schaaf A, Langendijk JA, Both S. Can the mean linear energy transfer of organs be directly related to patient toxicities for current head and neck cancer intensity-modulated proton therapy practice? Radiother Oncol 2021;165:159-65. [PMID: 34534614 DOI: 10.1016/j.radonc.2021.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sørensen BS, Pawelke J, Bauer J, Burnet NG, Dasu A, Høyer M, Karger CP, Krause M, Schwarz M, Underwood TSA, Wagenaar D, Whitfield GA, Lühr A. Does the uncertainty in relative biological effectiveness affect patient treatment in proton therapy? Radiother Oncol 2021;163:177-84. [PMID: 34480959 DOI: 10.1016/j.radonc.2021.08.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
14 Deng W, Yang Y, Liu C, Bues M, Mohan R, Wong WW, Foote RH, Patel SH, Liu W. A Critical Review of LET-Based Intensity-Modulated Proton Therapy Plan Evaluation and Optimization for Head and Neck Cancer Management. Int J Part Ther 2021;8:36-49. [PMID: 34285934 DOI: 10.14338/IJPT-20-00049.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
15 Kalholm F, Grzanka L, Traneus E, Bassler N. A systematic review on the usage of averaged LET in radiation biology for particle therapy. Radiother Oncol 2021;161:211-21. [PMID: 33894298 DOI: 10.1016/j.radonc.2021.04.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
16 Bauer J, Bahn E, Harrabi S, Herfarth K, Debus J, Alber M. How can scanned proton beam treatment planning for low-grade glioma cope with increased distal RBE and locally increased radiosensitivity for late MR-detected brain lesions? Med Phys 2021;48:1497-507. [PMID: 33506555 DOI: 10.1002/mp.14739] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
17 Buchsbaum JC. Comments on "Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in paediatric craniopharyngioma" by Toussaint, et al.: Prior Similar Field Arrangement Work and a Need for Variable RBE Use. Radiother Oncol 2021;158:327-9. [PMID: 33548283 DOI: 10.1016/j.radonc.2020.11.035] [Reference Citation Analysis]
18 Hahn C, Eulitz J, Peters N, Wohlfahrt P, Enghardt W, Richter C, Lühr A. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy. Med Phys 2020;47:6151-62. [PMID: 33118161 DOI: 10.1002/mp.14560] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
19 Toma-Dasu I, Dasu A, Vestergaard A, Witt Nyström P, Nyström H. RBE for proton radiation therapy - a Nordic view in the international perspective. Acta Oncol 2020;59:1151-6. [PMID: 33000988 DOI: 10.1080/0284186X.2020.1826573] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]